Related Experiment Video
Updated: Feb 4, 2026
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Genetics of Dilated Cardiomyopathy
1Drexel University College of Medicine, 2900 W. Queen Lane, Philadelphia, PA, 19129, USA.
Insights
Dilated cardiomyopathy (DCM) is a common heart condition often linked to genetic mutations. Understanding these gene variants is key to developing targeted treatments and improving patient diagnosis and management.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is the most prevalent cardiomyopathy, characterized by left ventricular dilation and impaired systolic function.
- Familial DCM constitutes a significant proportion of cases, with around 40 identified genes implicated in heart failure pathogenesis.
- Genetic factors play a crucial role in the development and progression of DCM.
Purpose of the Study:
- To review recent findings on gene mutations associated with DCM.
- To summarize the current understanding of the most common genetic variants contributing to DCM.
- To highlight the impact of genetic mutations on DCM pathogenesis and clinical presentation.
Main Methods:
- Utilizing next-generation sequencing for comprehensive gene analysis.
- Employing genotype-phenotype association studies to link genetic variants with clinical outcomes.
- Leveraging whole-exome sequencing to explore disease natural history and identify novel mutation variants.
Main Results:
- Next-generation sequencing facilitates the discovery of diverse mutation variants and their correlation with clinical presentations.
- Genotype-phenotype association analysis provides insights into the impact of specific mutations.
- Understanding pathogenic mechanisms of genetic abnormalities aids in developing targeted therapeutic strategies.
Conclusions:
- Advances in genetic analysis are crucial for understanding DCM.
- Identifying specific gene mutations offers hope for novel treatment options.
- Genetic assessment and counseling are vital for early diagnosis and improved clinical management of DCM patients and their families.
Purpose Of Review:
Dilated cardiomyopathy (DCM) is characterized by left ventricular dilation and systolic function and is the most common among all cardiomyopathies. Familial DCM makes up a significant portion of cases, and approximately 40 genes are identified as involved in the pathogenesis of heart failure, each affecting a specific part of cellular mechanisms. The purpose of this review is to summarize recent findings and the current understanding of the most common gene mutations identified associated with DCM.
Recent Findings:
Next-generation sequencing is a comprehensive gene analysis technique used to discover more mutation variants and also to learn about the impact of mutations in relationship to clinical presentations. A variety of techniques are utilized to study different gene mutations, such as genotype-phenotype association analysis or whole-exome sequencing, to understand the natural history of diseases. For certain genetic abnormalities, information is helpful in developing potential therapeutic treatment targeting mutations. More treatment options are hopeful with the understanding of specific genetic mutations and their pathogenic mechanism. It also suggests the importance of genetic assessment and counseling for family members of an affected patient, in order to provide potential early diagnosis and better clinical management of DCM.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
01:29Cardiomyopathy V: Interprofessional Care
01:25Cardiomyopathy I: Introduction and Classification
01:29Cardiomyopathy VI: Nursing Management